Image not available in RecallScope.
UCB Japan “Cimzia Subcutaneous Injection 200mg AutoClicks” - Recall
Official notice
16 Oct 2026
Last checked
27 Oct 2026
An official CAA Japan notice concerns UCB Japan “Cimzia Subcutaneous Injection 200mg AutoClicks” - Recall. A defect has been confirmed in which the needle does not fully retract after injection. Reason for recall: A defect has been confirmed in some lots in which the needle does not fully retract after injection. As this defect may leave the used needle exposed, the affected lots will be voluntarily recalled. The cause has been identified and countermeasures have already been implemented. Specific potential health effects: It has been confirmed that the full dose can be administered even if the needle does not fully retract after use. An exposed used needle may cause a needlestick injury, but any anticipated needlestick injury would be superficial. Systemic infection could occur only if several conditions were met in succession, so serious adverse health effects are considered highly unlikely. No serious adverse health effects attributable to this defect have been reported to date. Published 2026-10-16.
What to do now
All shipment destinations for the affected lots are known. The affected recipients will be notified of the recall, and the voluntary recall will be carried out promptly.
Recall number
2-12993
Official notice
2026-10-16
The hazard
The hazard
A defect has been confirmed in which the needle does not fully retract after injection. Reason for recall: A defect has been confirmed in some lots in which the needle does not fully retract after injection. As this defect may leave the used needle exposed, the affected lots will be voluntarily recalled. The cause has been identified and countermeasures have already been implemented. Specific potential health effects: It has been confirmed that the full dose can be administered even if the needle does not fully retract after use. An exposed used needle may cause a needlestick injury, but any anticipated needlestick injury would be superficial. Systemic infection could occur only if several conditions were met in succession, so serious adverse health effects are considered highly unlikely. No serious adverse health effects attributable to this defect have been reported to date.
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Lots
Expiry Dates
Recall Numbers
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand
Manufacturer
Phone
Brand: ユーシービージャパン. Contact: ユーシービージャパン株式会社 品質保証部. Phone 0120-093-189.
Source & status
Source & status
Recall details
Recall details
Recall number
Event id
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.
This recall was published 16 Oct 2026. The next one won't wait for you to search.
RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.
